Alvotech

NasdaqGM:ALVO Stock Report

Market Cap: US$2.4b

Alvotech Future Growth

Future criteria checks 6/6

Alvotech is forecast to grow earnings and revenue by 50.4% and 25.3% per annum respectively. EPS is expected to grow by 49.4% per annum. Return on equity is forecast to be 230.9% in 3 years.

Key information

50.4%

Earnings growth rate

49.37%

EPS growth rate

Biotechs earnings growth23.7%
Revenue growth rate25.3%
Future return on equity230.90%
Analyst coverage

Low

Last updated14 Oct 2025

Recent future growth updates

Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 24
Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Recent updates

Alvotech: Promising Vertically Integrated Biosimilar Platform

Oct 15

Alvotech (NASDAQ:ALVO) Held Back By Insufficient Growth Even After Shares Climb 29%

May 25
Alvotech (NASDAQ:ALVO) Held Back By Insufficient Growth Even After Shares Climb 29%

Alvotech's (NASDAQ:ALVO) Promising Earnings May Rest On Soft Foundations

May 15
Alvotech's (NASDAQ:ALVO) Promising Earnings May Rest On Soft Foundations
User avatar

Biosimilar Pipeline And R&D Capability Will Open New Markets

Upcoming biosimilar launches and strategic manufacturing expansions might drive substantial revenue and margin growth, leveraging lost biologic patents.

Benign Growth For Alvotech (NASDAQ:ALVO) Underpins Stock's 25% Plummet

Apr 08
Benign Growth For Alvotech (NASDAQ:ALVO) Underpins Stock's 25% Plummet

Alvotech's Position In The Coming Biosimilar Gold Rush

Nov 21

Alvotech: Steady Progress Offers A Good Chance Of Upside

Aug 26

Bullish: Analysts Just Made A Huge Upgrade To Their Alvotech (NASDAQ:ALVO) Forecasts

May 28
Bullish: Analysts Just Made A Huge Upgrade To Their Alvotech (NASDAQ:ALVO) Forecasts

Alvotech: Consider Buying As Positive Q1 Earnings Release Likely

Apr 25

Alvotech (NASDAQ:ALVO) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Apr 03
Alvotech (NASDAQ:ALVO) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 24
Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Analysts Just Shaved Their Alvotech (NASDAQ:ALVO) Forecasts Dramatically

Sep 03
Analysts Just Shaved Their Alvotech (NASDAQ:ALVO) Forecasts Dramatically

Positive Sentiment Still Eludes Alvotech (NASDAQ:ALVO) Following 27% Share Price Slump

May 05
Positive Sentiment Still Eludes Alvotech (NASDAQ:ALVO) Following 27% Share Price Slump

Earnings and Revenue Growth Forecasts

NasdaqGM:ALVO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,2444243263464
12/31/20269132922172224
12/31/20256552661921745
6/30/202556263-140-43N/A
3/31/202558897-225-149N/A
12/31/2024492-232-294-237N/A
9/30/2024394-441-301-265N/A
6/30/2024309-618-343-310N/A
3/31/2024114-494-339-301N/A
12/31/202393-552-359-312N/A
9/30/202364-596-356-309N/A
6/30/202365-416-347-299N/A
3/31/2023100-713-411-361N/A
12/31/202285-514-361-312N/A
9/30/20229661-388-319N/A
6/30/202278-12-345-285N/A
3/31/202239-42-274-223N/A
12/31/202140-102-269-228N/A
12/31/202069-170-86-74N/A
12/31/201983-210-97-89N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ALVO's forecast earnings growth (50.4% per year) is above the savings rate (3.1%).

Earnings vs Market: ALVO's earnings (50.4% per year) are forecast to grow faster than the US market (16.1% per year).

High Growth Earnings: ALVO's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: ALVO's revenue (25.3% per year) is forecast to grow faster than the US market (10.5% per year).

High Growth Revenue: ALVO's revenue (25.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ALVO's Return on Equity is forecast to be very high in 3 years time (230.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/03 17:12
End of Day Share Price 2025/10/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alvotech is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew BaumCitigroup Inc
Peter VerdultCitigroup Inc
Emmanuel PapadakisDeutsche Bank